Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares, for the month of September 2017. The filing serves to distribute a press release issued on September 28, 2017, to U.S. investors. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page, signature block, and exhibit reference for a press release. It does not include the actual text of the press release or any specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
No material changes versus the prior comparable period can be identified as the source text does not contain comparative financial data or operational updates.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements would be contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input content.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing an external press release (Exhibit 99.1) rather than a standalone financial report.
- Specific financial results for the period ending September 28, 2017, are not disclosed in the provided text.
- Investors must locate and review the full text of the September 28, 2017, press release to obtain revenue, earnings, and guidance figures.
- The document is signed by CEO Rice Powell and CFO Michael Brosnan.